YacobiAUdallJALevyG.Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther. 1976;19(5, pt 1):552-558. doi:10.1016/j.biopha.2017.01.092.
4.
PoórMBodaGNeedsPWKroonPALemliBBencsikT.Interaction of quercetin and its metabolites with warfarin: displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme. Biomed Pharmacother. 2017;88:574-581. doi:10.1016/j.biopha.2017.01.092.
5.
HornJRHanstenPDChanLN.Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674-680. doi:10.1345/aph.1H423.
6.
NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.154.